Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary MDS/AML that develops after acquired aplastic anemia Meeting Abstract


Authors: Connor, M. P.; Prathapa, N.; Frey, N. V.; Gill, S.; Hexner, E. O.; Bruno, X. J.; Lai, C.; Loren, A. W.; Luger, S. M.; Matthews, A. H.; McCurdy, S. R.; Perl, A.; Porter, D. L.; Zeringue, A.; Oved, J. H.; Olson, T. S.; Pratz, K. W.; Babushok, D. V.
Abstract Title: Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary MDS/AML that develops after acquired aplastic anemia
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-02
Start Page: 2720
Language: English
ACCESSION: WOS:001159740301120
DOI: 10.1182/blood-2023-179383
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joseph Hai Oved
    38 Oved